Analyst Ratings for SXC Health Solutions (SXCI)
SXCI Rating Summary
SXCI Price Target Summary
- Highest: $120.00 (Goldman Sachs)
- Lowest: $49.00 (UBS)
- Average: $98.55
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$98.55 (+5.9%)
Avg. $ Target:
$98.55 (+5.9%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/9/2012 | Barclays | New Coverage | Overweight (N/A) |
116.00 (N/A) |
95.41 | 93.02 | -2.5% | Details |
| 7/6/2012 | Goldman Sachs | New Coverage | Buy (N/A) |
120.00 (N/A) |
96.37 | 93.02 | -3.48% | Details |
| 7/3/2012 | JPMorgan | New Coverage | Overweight (N/A) |
109.00 (N/A) |
96.98 | 93.02 | -4.08% | Details |
| 6/25/2012 | CIBC | New Coverage | Sector Perform (N/A) |
105.00 (N/A) |
95.51 | 93.02 | -2.61% | Details |
| 6/22/2012 | Credit Suisse | Upgrade | Outperform (Neutral) |
109.00 (89.00) |
93.28 | 93.02 | -0.28% | Details |
| 3/16/2012 | BMO Capital | Downgrade | Market Perform (N/A) |
75.00 (N/A) |
73.14 | 93.02 | 27.18% | Details |
| 1/17/2012 | Morgan Stanley | Downgrade | Equalweight (N/A) |
N/A (N/A) |
62.64 | 93.02 | 48.5% | Details |
| 11/21/2011 | Cowen | Upgrade | Outperform (N/A) |
N/A (N/A) |
53.16 | 93.02 | 74.98% | Details |
| 11/18/2011 | GMP Securities | Upgrade | Buy (N/A) |
N/A (N/A) |
52.74 | 93.02 | 76.37% | Details |
| 10/4/2011 | Oppenheimer | New Coverage | Perform (N/A) |
N/A (N/A) |
51.79 | 93.02 | 79.61% | Details |
| 9/12/2011 | TD Securities » Updated 7/6/2012 |
New Coverage | Buy (N/A) |
116.00 (106.00) |
51.41 | 93.02 | 80.94% | Details |
| 8/9/2011 | Dougherty & Co | Upgrade | Buy (N/A) |
65.00 (N/A) |
45.43 | 93.02 | 104.75% | Details |
| 6/23/2011 | FBR Capital | New Coverage | Outperform (N/A) |
N/A (N/A) |
55.36 | 93.02 | 68.03% | Details |
| 5/19/2011 | Jefferies » Updated 6/27/2012 |
New Coverage | Buy (N/A) |
110.00 (N/A) |
58.88 | 93.02 | 57.98% | Details |
| 4/20/2011 | BB&T Capital | New Coverage | Buy (N/A) |
N/A (N/A) |
57.35 | 93.02 | 62.2% | Details |
